RITUXIMAB PLUS MULTIAGENT CHEMOTHERAPY FOR NEWLY DIAGNOSED CD20-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PROSPECTIVE MULTICENTER PHASE II STUDY (RADICAL; KALLA0804) BY KOREAN ADULT ALL WORKING PARTY
RITUXIMAB PLUS MULTIAGENT CHEMOTHERAPY FOR NEWLY DIAGNOSED CD20-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PROSPECTIVE MULTICENTER PHASE II STUDY (RADICAL; KALLA0804) BY KOREAN ADULT ALL WORKING PARTY
저자
Kim, D. Y.; Lee, J. H.; Lee, K. H.; Do, Y. R.; Kim, J. S.; Park, Y.; Kim, I.; Ahn, J. S.; Yang, D. H.; Lee, J. J.; Lee, H. S.; Jo, J. C.; Kim, H.; Moon, J. H.; Sohn, S. K.; Lee, W. S.; Lee, S. M.; Hyun, M. S.; Kim, M. K.; Lee, H.; Eom, H. S.; Kim, S. H.; Cho, Y. U.; Jang, S.; Park, C. J.; Joo, Y. D.